JP2007516218A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007516218A5 JP2007516218A5 JP2006528067A JP2006528067A JP2007516218A5 JP 2007516218 A5 JP2007516218 A5 JP 2007516218A5 JP 2006528067 A JP2006528067 A JP 2006528067A JP 2006528067 A JP2006528067 A JP 2006528067A JP 2007516218 A5 JP2007516218 A5 JP 2007516218A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxy
- pharmaceutical composition
- methyl
- composition according
- phenylisoquinolin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50510103P | 2003-09-23 | 2003-09-23 | |
| US60/505,101 | 2003-09-23 | ||
| PCT/US2004/030431 WO2005030791A2 (en) | 2003-09-23 | 2004-09-17 | Isoquinolinone potassium channel inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007516218A JP2007516218A (ja) | 2007-06-21 |
| JP2007516218A5 true JP2007516218A5 (cg-RX-API-DMAC10.html) | 2007-08-02 |
| JP4718467B2 JP4718467B2 (ja) | 2011-07-06 |
Family
ID=34392976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006528067A Expired - Fee Related JP4718467B2 (ja) | 2003-09-23 | 2004-09-17 | イソキノリノンカリウムチャネル阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7723352B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1667982B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP4718467B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN1856476A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2004276236B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2539814C (cg-RX-API-DMAC10.html) |
| WO (1) | WO2005030791A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7709476B2 (en) * | 2003-09-23 | 2010-05-04 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| CN1856477A (zh) * | 2003-09-23 | 2006-11-01 | 默克公司 | 异喹啉钾通道抑制剂 |
| US7781457B2 (en) * | 2003-09-23 | 2010-08-24 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| US7723352B2 (en) * | 2003-09-23 | 2010-05-25 | Merck Sharp & Dohme | Isoquinolinone potassium channel inhibitors |
| CA2539729C (en) * | 2003-09-23 | 2010-09-07 | Merck & Co., Inc. | Isoquinolinone potassium channel inhibitors |
| US7723290B2 (en) | 2004-10-22 | 2010-05-25 | Bioincept, Llc | Compositions and methods for modulating the immune system |
| US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
| EP1781635B1 (en) | 2004-07-29 | 2012-06-13 | Merck Sharp & Dohme Corp. | Potassium channel inhibitors |
| DE102005028862A1 (de) * | 2005-06-22 | 2007-01-11 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| EP1899322B1 (en) | 2005-06-28 | 2009-09-02 | Sanofi-Aventis | Isoquinoline derivatives as inhibitors of rho-kinase |
| PT1910333E (pt) | 2005-07-26 | 2013-08-01 | Sanofi Sa | Derivados de isoquinolona substituída com piperidinilo como inibidores da rho-cinase |
| HRP20110839T1 (hr) | 2005-07-26 | 2011-12-31 | Sanofi | Derivati cikloheksaminizokinolona kao inhibitori rho-kinaze |
| GB0525164D0 (en) | 2005-12-09 | 2006-01-18 | Xention Discovery Ltd | Compounds |
| WO2007098386A1 (en) * | 2006-02-17 | 2007-08-30 | Janssen Pharmaceutica N.V. | Pyrazolylquinazolinones as potassium channel openers |
| BRPI0720710A2 (pt) * | 2006-12-27 | 2014-12-23 | Sanofi Aventis | Derivados de isoquinolona e isoquinolinona substituídos com cicloalquilamina |
| JP5421783B2 (ja) | 2006-12-27 | 2014-02-19 | サノフイ | Ｒｈｏキナーゼ阻害剤としての置換イソキノロン及びイソキノリノン誘導体 |
| EP2102164B1 (en) | 2006-12-27 | 2010-12-01 | Sanofi-Aventis | Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives |
| KR20090094338A (ko) | 2006-12-27 | 2009-09-04 | 사노피-아벤티스 | 치환된 이소퀴놀린 및 이소퀴놀리논 유도체 |
| AU2007338410B2 (en) * | 2006-12-27 | 2012-08-16 | Sanofi-Aventis | Cycloalkylamine substituted isoquinoline derivatives |
| CN101595094B (zh) | 2006-12-27 | 2013-02-20 | 塞诺菲-安万特股份有限公司 | 环烷基胺取代的异喹诺酮衍生物 |
| ATE502027T1 (de) | 2006-12-27 | 2011-04-15 | Sanofi Aventis | Substituierte isochinoline und ihre verwendung als rho-kinase-inhibitoren |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| US9623021B2 (en) * | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| KR101638035B1 (ko) | 2007-01-22 | 2016-07-11 | 지티엑스, 인코포레이티드 | 핵 수용체에 결합하는 물질 |
| SI2303845T1 (sl) | 2008-06-24 | 2013-12-31 | Sanofi | Bi- in policiklični substituirani izokinolin in izokinolinski derivati kot inhibitorji rho-kinaze |
| PL2313374T3 (pl) | 2008-06-24 | 2014-03-31 | Sanofi Sa | 6-podstawione izochinoliny i izochinolinony |
| PE20110059A1 (es) | 2008-06-24 | 2011-02-15 | Sanofi Aventis | Isoquinolinas e isoquinolinonas sustituidas en calidad de inhibidores de la rho-quinasa |
| GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815784D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| US9737585B2 (en) | 2011-03-02 | 2017-08-22 | Bioincept, Llc | Compositions and methods for treatment of intracellular damage and bacterial infection |
| WO2013142390A1 (en) * | 2012-03-21 | 2013-09-26 | Gtx, Inc. | Aldo-keto reductase subfamily 1c3 (akr1c3) inhibitors |
| EP3290407B1 (en) * | 2013-10-18 | 2020-01-01 | Celgene Quanticel Research, Inc | Bromodomain inhibitors |
| EA038715B1 (ru) * | 2014-01-24 | 2021-10-08 | Селджен Квонтисел Рисёрч, Инк. | Ингибиторы бромодомена |
| AR104259A1 (es) | 2015-04-15 | 2017-07-05 | Celgene Quanticel Res Inc | Inhibidores de bromodominio |
| WO2017040186A1 (en) | 2015-08-28 | 2017-03-09 | Bioincept, Llc | Compositions and methods for the treatment of neurodamage |
| US11096987B2 (en) | 2015-08-28 | 2021-08-24 | Bioincept, Llc | Mutant peptides and methods of treating subjects using the same |
| AU2017252276A1 (en) | 2016-04-18 | 2018-11-15 | Celgene Quanticel Research, Inc. | Therapeutic compounds |
| US10150754B2 (en) | 2016-04-19 | 2018-12-11 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| AU2021247285A1 (en) | 2020-04-03 | 2022-10-27 | Vertex Pharmaceuticals Incorporated | Modulators of alpha-1 antitrypsin |
| CN115697969B (zh) * | 2020-04-03 | 2026-08-11 | 弗特克斯药品有限公司 | α-1抗胰蛋白酶调节剂 |
| JP7732999B2 (ja) | 2020-04-03 | 2025-09-02 | バーテックス ファーマシューティカルズ インコーポレイテッド | アルファ１－アンチトリプシンのモジュレーター |
| EP4188931A2 (en) | 2020-07-27 | 2023-06-07 | Vertex Pharmaceuticals Incorporated | Processes for preparing modulators of alpha-1 antitrypsin |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3594380A (en) | 1969-02-18 | 1971-07-20 | American Home Prod | Isoquinolin-1(2h)-ones |
| US3878215A (en) | 1971-12-01 | 1975-04-15 | Sandoz Ag | 2-Alkyl-3-substituted-4-aryl isoquinolines |
| US4897391A (en) | 1988-06-17 | 1990-01-30 | Schering Corporation | Tricyclic anti-allergy, antiinflammatory and anti-hyperproliferative compounds |
| DE69315920T2 (de) * | 1992-09-04 | 1998-06-10 | Takeda Chemical Industries Ltd | Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung |
| US5728712A (en) | 1995-05-19 | 1998-03-17 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
| CA2421819C (en) * | 2000-09-20 | 2010-03-09 | Merck & Co., Inc. | Isoquinolinone potassium channel inhibitors |
| US20040176361A1 (en) * | 2001-05-23 | 2004-09-09 | Masakazu Fujio | Fused heterocyclic compound and medicinal use thereof |
| US7402595B2 (en) | 2002-02-13 | 2008-07-22 | Takeda Pharmaceutical Company Limited | JNK inhibitor |
| US7709476B2 (en) * | 2003-09-23 | 2010-05-04 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| US7723352B2 (en) * | 2003-09-23 | 2010-05-25 | Merck Sharp & Dohme | Isoquinolinone potassium channel inhibitors |
| CN1856477A (zh) * | 2003-09-23 | 2006-11-01 | 默克公司 | 异喹啉钾通道抑制剂 |
| US7781457B2 (en) * | 2003-09-23 | 2010-08-24 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| CA2539729C (en) * | 2003-09-23 | 2010-09-07 | Merck & Co., Inc. | Isoquinolinone potassium channel inhibitors |
-
2004
- 2004-09-17 US US10/571,870 patent/US7723352B2/en not_active Expired - Fee Related
- 2004-09-17 WO PCT/US2004/030431 patent/WO2005030791A2/en not_active Ceased
- 2004-09-17 EP EP04788811.0A patent/EP1667982B1/en not_active Expired - Lifetime
- 2004-09-17 CA CA2539814A patent/CA2539814C/en not_active Expired - Fee Related
- 2004-09-17 AU AU2004276236A patent/AU2004276236B2/en not_active Ceased
- 2004-09-17 CN CNA2004800273696A patent/CN1856476A/zh active Pending
- 2004-09-17 JP JP2006528067A patent/JP4718467B2/ja not_active Expired - Fee Related
-
2010
- 2010-04-02 US US12/753,572 patent/US8338449B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007506748A5 (cg-RX-API-DMAC10.html) | ||
| JP2007506742A5 (cg-RX-API-DMAC10.html) | ||
| CA2539814A1 (en) | Isoquinolinone potassium channel inhibitors | |
| Kolb et al. | Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system | |
| WO2001032624A1 (en) | 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin | |
| JP2009120619A (ja) | 心不全の予防又は治療のための医薬組成物 | |
| EP1246806A1 (en) | Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin | |
| JP2009524676A5 (cg-RX-API-DMAC10.html) | ||
| US20090215745A1 (en) | Association of a sinus node If current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it | |
| ES2296964T3 (es) | Compuestos a base de nitrato organico para el tratamiento de ateroesclerosis y enfermedades vasculares. | |
| Aizawa et al. | Conductive property of the zone of slow conduction of reentrant ventricular tachycardia and its relation to pacing induced terminability | |
| US6110927A (en) | Loratadine for use as an antiarrhythmic | |
| WO2011012527A1 (en) | Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients | |
| JP2934323B2 (ja) | 抗血栓性化合物 | |
| US20040167200A1 (en) | Pharmaceutical composition and method of modulating cholinergic function in a mammal | |
| Coleman et al. | Antiarrhythmic Agents | |
| Fragakis et al. | Arrhythmias in the elderly: Modern management | |
| Kołodziej et al. | Case report Brugada syndrome–underestimated cause of sudden cardiac death in patients without an organic cardiac disease–a case report | |
| Garg et al. | Atrial flutter | |
| HK1106442B (en) | Association of a sinus node if, current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it | |
| Patti et al. | with Atrial Fibrillation on Triple Therapy of Non-vitamin K Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel | |
| Yusuf et al. | Ischemic heart disease: the next target for the angiotensin-converting enzyme inhibitors | |
| Yapici et al. | The effects of isradipine during and after coronary artery bypass surgery: A-24 | |
| Gašparović et al. | Atrial Velocity and Deformation as Markers of Atrial Mechanical Transport Following Atrial Fibrillation Surgery Using Transesophageal Doppler Myocardial Imaging | |
| Schoonderwoerd et al. | New therapeutic approaches |